Further to DrugAlert vol 1039, HPS Pharmacies wish to advise that all brands are continuing to experience a supply interruption for salbutamol 5mg nebules as follows:
Ventolin® Nebules
Salbutamol 5mg/2.5mL
ARTG 12534
Salbutamol Cipla Inhalation Ampoules
Salbutamol 5mg/2.5mL
ARTG 115657
Normal supplies of Salbutamol Cipla 5mg inhalation ampoules and Ventolin 5mg nebules are expected to return by the end of June 2026.
Salbutamol 2.5mg nebules are now also experiencing a supply interruption due to increased demand. Normal supplies of Ventolin® 2.5mg/2.5ml nebules are expected to return by mid-July 2026 and Salbutamol Cipla 2.5mg inhalation ampoules by the end of October 2026.
An internationally registered alternative of salbutamol 5mg nebules has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that S19A products may have a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates